Boston Avenue Capital

Boston Avenue Capital is an investment management firm based in Tulsa, Oklahoma, that specializes in activist investing within the small-cap and micro-cap markets. The firm is particularly known for its involvement in the life sciences and biotechnology sectors, where it frequently engages in proxy contests to influence corporate governance and strategic decision-making. Led by Charles M. Gillman, Boston Avenue Capital seeks to identify undervalued companies and implement changes to maximize shareholder returns. The firm does not develop its own therapeutic pipeline but rather manages a portfolio of equity positions in various industries, with a heavy emphasis on the healthcare sector. Notable past involvements include activist campaigns at companies such as Vanda Pharmaceuticals and AVEO Oncology.